Cite
MLA Citation
C Marton et al.. “40PInterest and potential of genetically engineered cord blood derived T cells for cancer immunotherapy.” Annals of oncology, vol. 29, n.d., p. . http://access.bl.uk/ark:/81055/vdc_100095511213.0x00003a
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
C Marton et al.. “40PInterest and potential of genetically engineered cord blood derived T cells for cancer immunotherapy.” Annals of oncology, vol. 29, n.d., p. . http://access.bl.uk/ark:/81055/vdc_100095511213.0x00003a